Sentence examples for most studied cancers from inspiring English sources

Colorectal cancer (CRC) is one of the most studied cancers because of its high prevalence and number of deaths.

Breast cancer (BC) is one of the most studied cancers because it is the principal cause of cancer deaths in women.

Examining one of the most studied cancers, a childhood leukemia, a team in Tennessee has now cataloged exactly what happens to these leukemia cells in youngsters who relapse.

Breast cancer is one of the most studied cancers in proteomics.

Examples of three of the most studied cancers, lung, breast, and ovarian cancers, have been discussed illustrating various perspectives in approaching the subject of cancer biomarkers, the need to standardize and optimize study design, preanalytical and analytical assays components, and strict validation strategies.

In "Proteomics in Cancer Biomarkers Discovery: Challenges and Applications," R. M. Sallam provided us with a perspective review that summarizes the potential use of proteomics approach to identify molecular targets in cancer research with examples of three of the most studied cancers including lung, breast, and ovarian cancers.

The 10 most studied cancer cell gene variants were TP53 and cisplatin/5-fluorouracil/paclitaxel response, ERBB2 (HER2/neu) and anthracyclines/trastuzumab response, EGFR and gefitinib response, and RAS, FLT3, ABCB1, BCL2 and t(9 22) and other karyotype and cytogenetic mutations and response to a variety of combination chemotherapy regimens.

In the data collected by the ICGC, breast cancer is the most studied cancer type in which more than 1,100 individuals have been screened.

Surprisingly, the expression of RNA-binding proteins (RBPs), master regulators of post-transcriptional gene expression, was also significantly changed across most studied cancer types.

Current evidence suggests that the type and stage of the cancer is likely to be important, with hormone-dependent cancers possibly reacting differently to cannabinoid exposure than gliomas (the most studied cancer type in terms of cannabinoid action).

To conclude that not all the submitters' abide 100% by the compliant standards, we investigated if this trend is same for all other disease domains; we chose one among the most studied cancer disease, Lung Cancer, and generated similar results to AD. Supplementary Figure S5 shows the distribution of compliant standards across Lung Cancer studies.